Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference7 articles.
1. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis;Wang;Cochrane Database Syst Rev,2023
2. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study);Romualdi;Expert Rev Cardiovasc Ther,2011
3. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism;Büller;N Engl J Med,2012
4. Bibliometric analysis of adverse drug reactions to rivaroxaban;Du;Chin J Clin Pharmacol,2018
5. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies;Monagle;Lancet Haematol,2019